Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift

被引：0
|
作者：
Yun-Fan Liaw
机构：
[1] Chang Gung University College of Medicine,Liver Research Unit, Chang Gung Memorial Hospital
来源：
Hepatology International | 2019年 / 13卷
关键词：
Clinical relapse; Entecavir; Hepatitis flare; Hepatic decompenation; Sustained remission; Tenofovir;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：665 / 673
页数：8
相关论文
共 50 条
  • [31] Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?
    Elia Moreno-Cubero
    Robert T Sánchez del Arco
    Julia Pe?a-Asensio
    Eduardo Sanz de Villalobos
    Joaquín Míquel
    Juan Ramón Larrubia
    World Journal of Gastroenterology, 2018, 24 (17) : 1825 - 1838
  • [32] Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B
    Kaneko, Shun
    Kurosaki, Masayuki
    Mashiba, Toshie
    Marusawa, Hiroyuki
    Kondo, Masahiko
    Kojima, Yuji
    Uchida, Yasushi
    Fujii, Hideki
    Akahane, Takehiro
    Yagisawa, Hitoshi
    Kusakabe, Atsunori
    Kobashi, Haruhiko
    Abe, Takehiko
    Yoshida, Hideo
    Ogawa, Chikara
    Furuta, Koichiro
    Tamaki, Nobuharu
    Tsuji, Keiji
    Matsushita, Tomomichi
    Izumi, Namiki
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (01)
  • [33] Changes in the Hepatitis B Surface Antigen Level According to the HBeAg Status and Drug Used in Long-term Nucleos(t)ide Analog-treated Chronic Hepatitis B Patients
    Na, Jong Hwa
    Kim, Jeong Han
    Choe, Won Hyeok
    Kwon, So Young
    Yoo, Byung Chul
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2021, 77 (06) : 285 - 293
  • [34] Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B
    Lee, I-Cheng
    Sun, Cheuk-Kay
    Su, Chien-Wei
    Wang, Yuan-Jen
    Chang, Hung-Chuen
    Huang, Hui-Chun
    Lee, Kuei-Chuan
    Huang, Yi-Shin
    Perng, Chin-Lin
    Liu, Yuh-Hwa
    Chua, Chian-Sem
    Lin, Yu-Min
    Lin, Han-Chieh
    Huang, Yi-Hsiang
    MEDICINE, 2015, 94 (32)
  • [35] Efficacy of tenofovir switch therapy for nucleos(t)ide-experienced patients with chronic hepatitis B
    Lo, A. O. -S.
    Wong, V. W. -S.
    Wong, G. L. -H.
    Tse, Y. -K.
    Chan, H. -Y.
    Chan, H. L. -Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (11) : 1190 - 1199
  • [36] Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B
    Chotiyaputta, Watcharasak
    Peterson, Carolyn
    Ditah, Fausta A.
    Goodwin, Diane
    Lok, Anna S. F.
    JOURNAL OF HEPATOLOGY, 2011, 54 (01) : 12 - 18
  • [37] Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs
    Petersen, Joerg
    Buti, Maria
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (06) : 683 - 694
  • [38] Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain
    Ramos-Rincon, Jose-Manuel
    Pinargote-Celorio, Hector
    de Mendoza, Carmen
    Ramos-Belinchon, Clara
    Barreiro, Pablo
    Trevino, Ana
    Corral, Octavio
    Soriano, Vicente
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (05) : 540 - 548
  • [39] Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues
    Irene Rapti
    Stephanos Hadziyannis
    World Journal of Hepatology, 2015, 7 (08) : 1064 - 1073
  • [40] Benefits of nucleos(t)ide analog treatments for hepatitis B virus-related cirrhosis
    Honda, Koichi
    Seike, Masataka
    Murakami, Kazunari
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (22) : 2404 - 2410
12345